title: Cutaneous cryptococcus in an elderly woman with chronic essential dermatitis.
abstract: Cryptococcus neoformans is a common cause of life-threatening infection. Cutaneous manifestations of Cryptococcus can be primary or secondary, most commonly from immunosuppression. With the global emergence of acquired immunodeficiency syndrome (AIDS), incidence of cryptococcosis is increasing and now represents a major life-threatening fungal infection in these patients. Nonspecific lesions may cause misdiagnosis. Disseminated Cryptocoocus requires early clinical diagnosis and effective management to decrease mortality. We review a case of cutaneous Cryptococcus as a complication of chronic essential dermatitis treated with long-term immunosuppressive agents and discuss updated guidelines on the treatment of Cryptococcus.
authors.affiliation: Pennsylvania State Milton S. Hershey Medical Center, USA.
authors.forename: Sonia
authors.initials: S
authors.lastname: Badreshia
authors.forename: Stacy
authors.initials: S
authors.lastname: Klepeiss
authors.forename: Mike
authors.initials: M
authors.lastname: Ioffreda
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Miller
authors.forename: David R
authors.initials: DR
authors.lastname: Adams
authors.forename: Christine
authors.initials: C
authors.lastname: Mackley
mesh_terms: D000935:Antifungal Agents / Q000627:therapeutic use; D002908:Chronic Disease; D003453:Cryptococcosis / Q000188:drug therapy / Q000382:microbiology*; D003455:Cryptococcus neoformans; D003872:Dermatitis / Q000382:microbiology*; D003881:Dermatomycoses / Q000188:drug therapy / Q000382:microbiology*; D003937:Diagnosis, Differential; D005260:Female; D015725:Fluconazole / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged
chemical_list: D000935:Antifungal Agents; D015725:Fluconazole